← FDA DRUG APPROVALS
FDA NDA · NDA050648
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor: BAXTER HLTHCARE
APPLICATION
NDA050648
TYPE
NDA
ORIGINAL APPROVAL
1989-12-29
LATEST ACTION
1989-12-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
CLINDAMYCIN PHOSPHATE EQ 12MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
CLINDAMYCIN PHOSPHATE EQ 900MG BASE/100ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
CLINDAMYCIN PHOSPHATE EQ 6MG BASE/ML · INJECTABLE · INJECTION
Approval history
1989-12-29Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.